Vaxess Technologies celebrates the grand opening of their 3,600 square feet pilot GMP manufacturing facility on Monday.

Vaxess Technologies celebrates the grand opening of their 3,600 square feet pilot GMP manufacturing facility on Monday.
Watson-Marlow is pleased to announce that construction will start in October 2021, on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022.
Phillips-Medisize, announces the expansion of its global manufacturing footprint, along with extended product design, development and manufacturing capabilities to streamline the delivery of game-changing products and solutions.
Mile High Labs, a Colorado startup that calls itself the world’s largest manufacturer of products, purchased the plant in Broomfield, Colorado, for about $18.8 million.
Multinational pharmaceutical company GlaxoSmithKlyne (GSK) launched two new pharmaceutical manufacturing facilities and an expanded production building at its Jurong site. According to GSK, the new and expanded sites will allow the faster production of drugs and Active Pharmaceutical Ingredients (APIs) for clinical trials.
The first attempts have launched to bio-engineer protein biomaterials like those found in mussels and tree frogs to yield similar amazing wet adhesion in sealants, coatings, glues, and medical adhesives. Crucial proteins in these animals exhibit unique behaviors and chemical reactivity, and the NYU Tandon School of Engineering researchers are creating hydrogels that borrow certain key features of those proteins: the separation of a solution into two distinct liquids in response to external stimuli, the incorporation of nonstandard amino acids, and patterning, such as the polygonal pillars seen in the toe pads of tree frogs.
CU Boulder researchers have developed nanobio-hybrid organisms capable of using airborne carbon dioxide and nitrogen to produce a variety of plastics and fuels, a promising first step toward low-cost carbon sequestration and eco-friendly manufacturing for chemicals.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems.
More than 500 invited guests and customers of Romaco China and Truking recently attended the official opening of the new “Romaco China Solids Process Centre”. This high-tech laboratory on the Truking campus in Changsha is equipped with Innojet and Kilian machines.
Precigen commenced the build-out of the nearly 5,000 square foot manufacturing facility in 2018 to support gene therapy manufacturing. The good manufacturing practices (GMP) facility was designed with agility and control in mind, focusing on rapid manufacturing and the ability to scale production appropriately to meet early stage clinical trial needs.
Taking a cue from biological cells, researchers from MIT, Columbia University, and elsewhere have developed computationally simple robots that connect in large groups to move around, transport objects, and complete other tasks.
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications and rare diseases through gene therapy, cell therapy, exosomes, novel molecules and combinations with existing pharmaceuticals, announced today that it has received funding from the Israeli Ministry of the Economy to build a gene therapy facility.